3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
20
Lymphoma
6
Lymphoma, T-Cell, Peripheral
5
Lymphoma, T-Cell
5
Mycosis Fungoides
4
Lymphoma, T-Cell, Cutaneous
4
Lymphomatoid Papulosis
3
Lymphoma, Large-Cell, Anaplastic
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Lymphoma, Primary Cutaneous Anaplastic Large Cell
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Immunoblastic Lymphadenopathy
2
Hematologic Diseases
2
Enteropathy-Associated T-Cell Lymphoma
2
Squamous Cell Carcinoma of Head and Neck
1
Sezary Syndrome
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Mesothelioma, Malignant
1
Melanoma
1
Lymphoma, Extranodal NK-T-Cell
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Large Granular Lymphocytic
1
Leukemia
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Oxaliplatin
66
pembrolizumab
48
Fluorouracil
44
Capecitabine
39
Nivolumab
33
Leucovorin
32
Paclitaxel
28
Trastuzumab
21
Docetaxel
19
Cisplatin
18
S 1 (combination)
17
Bevacizumab
15
Drug Therapy
14
Ramucirumab
13
Irinotecan
13
tislelizumab
12
Cyclophosphamide
12
fludarabine
10
Carboplatin
10
sintilimab
9
Radiotherapy
9
Magnetic Resonance Spectroscopy
9
trastuzumab deruxtecan
8
atezolizumab
8
Specimen Handling
8
Biopsy
8
durvalumab
7
Surgical Procedures, Operative
7
Gemcitabine
7
zolbetuximab
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Brentuximab Vedotin
×
1 year
×
Clear all
No trials found.